R. Ismayilov Et Al. , "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma," EURASIAN JOURNAL OF MEDICINE , vol.54, no.1, pp.77-79, 2022
Ismayilov, R. Et Al. 2022. Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma. EURASIAN JOURNAL OF MEDICINE , vol.54, no.1 , 77-79.
Ismayilov, R., AKTEPE, O. H., Sardarova, K., LEBLEBİCİ, C. B., & ERMAN, M., (2022). Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma. EURASIAN JOURNAL OF MEDICINE , vol.54, no.1, 77-79.
Ismayilov, Rashad Et Al. "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma," EURASIAN JOURNAL OF MEDICINE , vol.54, no.1, 77-79, 2022
Ismayilov, Rashad Et Al. "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma." EURASIAN JOURNAL OF MEDICINE , vol.54, no.1, pp.77-79, 2022
Ismayilov, R. Et Al. (2022) . "Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma." EURASIAN JOURNAL OF MEDICINE , vol.54, no.1, pp.77-79.
@article{article, author={Rashad Ismayilov Et Al. }, title={Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma}, journal={EURASIAN JOURNAL OF MEDICINE}, year=2022, pages={77-79} }